Impact on stable chest pain pathways of CT fractional flow reserve

Rachel A O'Leary1, Julie Burn1, Samuel G Urwin1

  • 1Northern Medical Physics and Clinical Engineering, Newcastle Upon Tyne Hospitals NHS Foundation Trust, Newcastle Upon Tyne, UK.

Insights

Introducing CT fractional flow reserve (FFRCT) improved stable chest pain pathway efficiency and guideline adherence. This diagnostic tool reduced invasive procedures and unnecessary tests, streamlining patient care without affecting revascularisation rates.

Area of Science:

  • Cardiology
  • Medical Imaging
  • Health Services Research

Background:

  • Stable chest pain management pathways aim for efficient diagnosis and treatment.
  • National Institute for Health and Care Excellence (NICE) guidelines provide a framework for chest pain assessment.
  • CT fractional flow reserve (FFRCT) is a non-invasive imaging technique for assessing coronary artery disease.

Purpose of the Study:

  • To evaluate the impact of integrating FFRCT into rapid access chest pain clinic (RACPC) pathways.
  • To assess changes in guideline concordance, resource utilization, and revascularisation rates post-FFRCT implementation.
  • To compare patient outcomes before and after the introduction of FFRCT in a tertiary UK cardiac centre.

Main Methods:

  • A single-centre, before-and-after study design was employed.
  • Data were collected from electronic records and the Strategic Tracing Service for RACPC patients.
  • Patient cohorts from pre-FFRCT (July-Dec 2017) and post-FFRCT (Aug 2018-Jan 2019) periods were compared.

Main Results:

  • First-line CT coronary angiography (CTCA) use increased significantly post-FFRCT (50.6% vs 75.7%).
  • More patients reached a diagnostic endpoint after a single investigation (74.9% vs 84.9%).
  • There was a reduction in stress/rest myocardial perfusion scans and diagnostic-only angiograms, leading to fewer invasive procedures (29.3% vs 17.6%) and inpatient admissions (39.0% vs 24.3%). Revascularisation rates and time to revascularisation remained similar.

Conclusions:

  • FFRCT adoption enhanced compliance with NICE guidelines for chest pain management.
  • The introduction of FFRCT led to reduced use of invasive diagnostic angiography and fewer planned admissions.
  • FFRCT streamlined diagnostic pathways, reducing the need for multiple investigations to reach a management endpoint.
Abstract

Related Concept Videos

Flail Chest-II01:26

Flail Chest-II

Managing flail chest, a condition characterized by a segment of the chest wall moving independently from the rest of the thoracic cage, requires a comprehensive approach. It includes a thorough assessment of the patient's condition, a diagnostic evaluation to determine the extent of the injury, and the implementation of appropriate medical interventions tailored to the individual's needs.
Assessment:
1. Clinical Evaluation:
History:
218
Imaging Studies for Cardiovascular System V: CT01:28

Imaging Studies for Cardiovascular System V: CT

Cardiac computed tomography (CT) scanning is an advanced cardiac imaging technique that utilizes CT technology, with or without intravenous (IV) contrast, to produce accurate cross-sectional virtual slices of specific areas of the heart, coronary circulation, and major blood vessels such as the aorta, pulmonary veins, and arteries. The computer processes these slices to generate three-dimensional images. Multidetector CT (MDCT) is a rapid form of CT scanning that captures multiple slices...
52
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers01:26

Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers

Receptor tyrosine kinase inhibitors (TKIs) and calcium channel blockers (CCBs) are two critical categories of drugs employed in the treatment of pulmonary artery hypertension (PAH). PAH is a disease that causes high blood pressure in the pulmonary arteries, resulting in chest pain, fatigue, and shortness of breath.
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
215
Angina III: Clinical Manifestations and Assessment01:29

Angina III: Clinical Manifestations and Assessment

Angina manifests as chest pain, tightness, or squeezing discomfort typically located behind the breastbone. It can radiate to the neck, jaw, shoulders, and inner aspects of the upper arms, most commonly the left arm. Patients may experience shortness of breath, fatigue, profuse sweating, dizziness, indigestion, heartburn, palpitations, anxiety, and vomiting as accompanying symptoms. This pain often lasts a few minutes and is triggered by physical exertion, emotional stress, heavy meals, or cold...
16
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
29
Chest Physiotherapy01:24

Chest Physiotherapy

Chest Physiotherapy (CPT) is a therapeutic technique used in respiratory care to improve ventilation, clear bronchial secretions, and enhance the efficiency of respiratory muscles. This therapy includes three primary procedures: postural drainage, percussion, and vibration. It can be performed on spontaneously breathing patients and those who are intubated and mechanically ventilated.
Purpose
CPT is primarily used for patients with excessive bronchial secretions who have difficulty clearing...
562